BioNTech is a biotechnology company based in Mainz, Germany, that develops medicines built on messenger RNA and other technologies. It is known for an mRNA vaccine against the coronavirus, developed with a large pharmaceutical partner, and it also pursues cancer immunotherapies and vaccines against infectious diseases. Its customers are mainly health authorities, governments and healthcare systems that purchase its vaccines, while its research pipeline targets oncology and other serious conditions.
BioNTech SE trades under the code 0A3M on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2592 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
36/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-11.2%
From 52-week high-27.5%
MomentumWeak
32/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-5.8%
6-month return-15.8%
12-month, skipping last month-6.2%
Stability (higher is calmer)Weak
42/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)44.2%
Worst drawdown, 1 year (smaller is calmer)-29.5%
LiquidityFair
62/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.52M USD
Zero-volume days5.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 79.51 – 123.69Daily closes, split-adjusted
Signals
50-day average98.45
200-day average97.45
Golden/death cross (60d)Golden, 23 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)7.07
Technical summary
Daily
Strongly bearish
2 bullish · 2 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
88.96
Bearish
EMA 10
89.42
Bearish
SMA 20
92.43
Bearish
EMA 20
91.74
Bearish
SMA 50
98.45
Bearish
EMA 50
94.72
Bearish
SMA 100
95.14
Bearish
EMA 100
95.64
Bearish
SMA 200
97.45
Bearish
EMA 200
96.99
Bearish
Oscillators (daily)
RSI (14)
34.49
Neutral
MACD (12, 26)
-2.82
Bearish
Momentum (12)
-10.26
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-86.50
Neutral
Pivot points (classic, last session)
S3
69.34
S2
77.92
S1
82.21
Pivot
90.79
R1
95.08
R2
103.7
R3
108.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 EUR
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1.5498
Ex-dividend dates and amounts from our market-data provider. Shown as declared, before tax.
Prices are end-of-day closes in USD. Educational only, not financial advice.
